Hypoxic Cells and Chemotherapy Enhancement
Author Information
Author(s): K.T. Wheeler, C.A. Wallen, K.L. Wolf, D.W. Siemann
Primary Institution: University of Kansas
Hypothesis
Hypoxic cells are required for misonidazole to potentiate the cell-killing effects of nitrosoureas.
Conclusion
The study found that hypoxic cells are necessary for misonidazole to enhance the effectiveness of certain chemotherapy drugs.
Supporting Evidence
- Misonidazole alone did not kill tumor cells.
- Combining misonidazole with BCNU significantly increased cell kill.
- Clamping tumors created a temporary hypoxic state.
- Intracerebral tumors were shown to contain no hypoxic cells.
Takeaway
This study shows that some cancer cells need to be in a low-oxygen state for a drug called misonidazole to help other cancer drugs work better.
Methodology
Rats with 9L tumors were treated with misonidazole and nitrosoureas, and tumor cell survival was measured after treatment.
Limitations
The study did not demonstrate chemopotentiation in intracerebral tumors, which may limit the generalizability of the findings.
Participant Demographics
Rats bearing 9L tumors were used in the experiments.
Statistical Information
P-Value
<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website